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treatment QA and the minimum number of clinical couples 
(DLG,TF) needed to ensure the acceptance of all plans. 
 
Results: The optimal couple of (DLG,TF) was found to vary 
with MLC motion complexity: as the MLC apertures became 
smaller and more irregular DLG and TF increase. As a 
consequence the optimal value of (DLG,TF) vary with district 
from (2mm,1.7%) for prostate plans to (2.35mm,1.9%) for 
H&N ones. Despite this rough classification, some differences 
within the same district can arise when target volumes are 
significantly different from typical values.Because of this 
differences the use of a single couple (DLG,TF) can lead to 
mean dose deviations as large as 5% between planned and 
delivered dose. In our case three different (DLG,TF) couples 
were found to be enough to ensure a local gamma (3%,3mm) 
passing rate larger than 95% for each plan.Once a significant 
database has been collected the optimal couple (DLG,TF) to 
be used for a new plan can be a priori decided considering 
the anatomical district. The choice can be then confirmed 
after a single optimization process computing the optimal 
couple for that plan and evaluating the distance from the 
clinical couple to foresee the expected degree of dosimetric 
agreement. 
 
Conclusion: Our work shows that a single optimal couple 
(DLG,TF) can not be found for all possible clinical plans, but 
three MLC configurations can be enough to ensure the 
accuracy of delivered dose. A method to identify the group of 
MLC configurations is proposed together with indications 
about how to identify the appropriate couple to be used for 
any plan. 
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Purpose or Objective: An Elekta MR-Linac (MRL) prototype 
has been installed at the author’s institute, combining 1.5 T 
magnetic resonance imaging (Philips) with linear accelerator 
treatment (Elekta). A novel method for alignment and use of 
a scanning water phantom has been established. The first 
data of sufficient precision and quantity to characterize the 
beam has been acquired in a 1.5 T magnetic field for the 
purposes of beam modelling and/or beam verification. 
 
Material and Methods: The isocentre is located at 143.5 cm 
from the linac target and is within an enclosed MRI-like bore 
which affects the use of a water phantom. A prototype MR-
compatible water phantom (PTW) was used to acquire 
percentage depth doses, inline and crossline scans, relative 
output factors and collimator scatter factors with a CC04 ion 
chamber (IBA) and a micro-diamond detector (PTW). An exit 
PDD showing the electron return effect was also acquired. 
Position and orientation of the phantom was established 
using radio-opaque markers and a gantry-mounted electronic 
portal imaging device.  
Linac-specific parameters such as gantry tilt, EPID rotation 
and isocentre location were independently checked using the 
water phantom.  
 
Results: The beam energy is consistent with a nominal 7.3 MV 
photon beam (TPR 0.702), however the depth of maximum 
dose is 13 mm, closer to the surface than in a standard field 
due to the 1.5 T magnetic field. Inline profiles are generally 
consistent with those of a standard flattening-filter-free 
beam, however the crossline profiles are clearly distinct with 
an off-axis shift and asymmetric penumbral shoulders and 
feet due to the Lorentz force of the magnetic field on the 
secondary electrons. Small field data were acquired taking 
into account the dose-shift due to the magnetic field.  
The relative output factors are consistent with those from a 
standard FFF beam, with no evidence of abnormal variation 
for small fields.  
Final results will be presented.  
 
Conclusion: Practical use of a scanning water tank has been 
established in an MRL. The data presented here comprises 
the first substantial collection of MRL data that can be used 
for beam characterization. The dataset is suitable for 
calculating relative doses and testing planning system model 
performance in a 1.5 T magnetic field.  
 
Poster: Physics track: Radiation protection, secondary 
tumour induction and low dose (incl. imaging)  
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Purpose or Objective: Secondary neutron dose is of 
particular concern in proton craniospinal irradiation (CSI) as 
this treatment is primarily used to treat children and 
adolescents, who are at significant risk of developing 
radiation-related late effects. While Monte Carlo techniques 
have been used to calculate such data for proton CSI, doses 
that are based on spectra measurements are lacking in the 
literature. Furthermore, the existing data are only reported 
for one of the proton beamline manufacturers. Given that 
doses from externally generated neutrons are highly 
dependent on the design of the proton therapy machine itself 
and treatment-specific devices within the beamline, there is 
a need to report doses for all beamlines used to treat proton 
CSI. Single-room compact proton systems are particularly 
noteworthy as many units are currently operational and more 
are being commissioned and installed. Therefore, the 
objectives of the present study, for a typical passively 
scattered proton CSI treatment, were to measure the 
secondary neutron spectra and calculate dose equivalents for 
neutrons delivered via a single-room compact system.  
 
Material and Methods: Secondary neutron spectra were 
measured using extended-range Bonner spheres for three 
different clinical CSI proton fields, including their respective 
brass apertures: whole brain, upper spine, and lower spine. 
For each field, measurements were repeated with an active 
scintillator and 18 different moderating. Measurements were 
performed with a water phantom at isocenter and the 
detector located at 50 cm from the isocenter along the 
patient plane. For each set of measurements, neutron 
spectra were determined by mathematical deconvolution of 
detector count rates. Ambient dose equivalents [H*(10)] were 
calculated using ICRP-74 conversion coefficients to the 
fluence spectra. 
 
Results: The measured neutron spectral fluence and H*(10) 
for each field are shown in Figure 1a and 1b, respectively. 
The energy distributions for each of the fluence spectra were 
similar, with a high-energy direct neutron peak, an 
evaporation peak, a thermal peak, and an intermediate 
continuum between the evaporation and thermal peaks. 
Neutrons in the evaporation peak made the largest 
contribution to the dose equivalent. The, H*(10) in mSv per 
proton Gy to isocenter were 3.94, 2.79, and 2.71 
respectively, for the brain, upper spine, and lower spine 
fields. Neutron fluence and H*(10) were approximately 1.6 
times higher for the brain field than for the spine fields, 
which is attributed to the greater range and modulation for 
the brain field than for the spine fields. 
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Conclusion: We measured neutron spectra and calculated 
neutron dose equivalents for a clinical treatment for a single 
gantry proton system, whose use and planned installations 
have recently increased. Data reported here are consistent 
with dose equivalents reported for CSI carried out with other 
proton therapy beamlines. 
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Purpose or Objective: More than half of cancer patients 
receive radiotherapy for radical or palliative purposes. 
Increasing survival rates in cancer patients make it important 
to study late side-effects, including secondary radiation-
induced cancers. Although a number of predictive models 
exist, the absolute accuracy of these models in the 
radiotherapy dose range is limited partly due to scarcity of 
data and partly by extrapolation beyond historical data 
bounds. The aim of this work is to investigate conversion of 
malignant induction probabilities, which provide useful 
relative risk estimates, into absolute life time attributable 
risk estimates (LAR) and excess absolute risk (EAR) by 
calibrating and benchmarking our models using published 
outcome data. 
 
Material and Methods: An in-house modelling tool, which 
calculates voxelwise risk estimates from patient-specific 3D 
dose distributions, was modified to generate linear-no-
threshold (LNT) model-based risk estimates for the whole 
body and per organ using organ-equivalent dose. Second 
cancer risk was calculated for uniform whole-body exposure 
of 0.1 Gy for comparison with tabulated BIER VII data. Model 
parameters initially used were taken from existing published 
reports for the relevant models. The calculated LAR was then 
compared to the BIER VII results and the linear coefficient, λ, 
was adjusted to make the model prediction better match the 
BEIR VII result. A similar calibration of parameters was then 
performed for the linear quadratic (LQ) and linear model 
(LIN) malignant induction coefficients. EAR was calculated 
for a dose range to compare results with published data.  
 
Results: After calibration, calculations of LAR for single 
uniform exposure of 0.1 Gy produced a value of 837 cases per 
100,000 for an exposure at age of 40, in comparison to 824 
according to BIER VII report. Averaging over ages at exposure 
of 20 to 80 produced a value within 5% of the BIER VII report. 
Calculations of EAR for a dose range relevant to RT of 1-6 Gy 
using the LIN model were always within the range of 
uncertainty due to differences in RBE neutron value in the 
independent published Hodgkin Lymphoma data (Schneider et 
al, 2008).  
 
 
 
Conclusion: These results show that our models can produce 
absolute LAR estimates for secondary cancer which are 
consistent with the values reported in the BEIR VII report for 
uniform irradiation to 0.1Gy. The comparison of our results of 
EAR using LIN model to published data showed agreement 
with independent published data of HL.  
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Purpose or Objective: There is increased use of proton 
therapy in pediatric cancer patients. In treatment planning, 
neutrons produced in the treatment delivery system and the 
patient are usually ignored and not documented. The goal of 
this ongoing project is to develop and establish a system for 
measuring and simulating 3D neutron and gamma radiation 
fields of passively scattered and actively scanned proton 
beams using representative clinical proton fields impinging on 
tissue-equivalent phantom materials. Eventually this should 
lead to a standardized approach for calculating organ neutron 
doses in paediatric proton patients. 
 
Material and Methods: The neutron dosimetry consists of 
neutron and gamma fluence measurements with an array of 
three organic scintillators positioned 70-80 cm lateral to 
blocks of tissue equivalent materials (soft tissue and compact 
